Table 4.
Clinical variables | Scale range | Total CI | Total MI-TA muscle |
---|---|---|---|
UPDRS postural stability (Item 3.12) | 0–2 | + 0.620 (0.054) | + 0.677(0.023) |
UPDRS rigidity (Item 3.3) | 0–5 | + 0.674 (0.011) | + 0.810 (0.033) |
UPDRS gait (Item 3.10) | 0–3 | + 0.759 (0.002) | + 0.820 (0.002) |
UPDRS body bradykinesia (Item 3.14) | 0–3 | + 0.778 (0.006) | + 0.625(0.015) |
UPDRS PIGD | 0–20 | + 0.858 (0.018) | + 0.788(0.012) |
Year of disease | 1–10 | + 0.554 (0.003) | + 0.687 (0.07) |
H & Y scale | 1–3 | + 0.347 (0.241) | + 0.578 (0.061) |
UPDRS III | 9–41 | + 0.388 (0.157) | + 0.738 (0.017) |
The ρ (p-value)—Spearman correlation coefficients (ρ) is indicated with level of significance (p). The acronyms used in the table—UPDRS III—Unified Parkinson’s Disease Rating Scale, UPDRS PIGD—UPDRS III Postural Instability and Gait Disturbance, H & Y Scale—Hoehn and Yahr scale